Market Overview

Biogen Phase 3 Study Of Aducanumab

Share:
Related BIIB
Benzinga's Top Upgrades, Downgrades For September 21, 2017
Biogen Spinoff Bioverativ Is A Buy

https://clinicaltrials.gov/ct2/show/NCT02477800

Posted-In: FDA

 

Related Articles (BIIB)

View Comments and Join the Discussion!
Loading...
Loading...